Key terms
About AVDL
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AVDL news
Yesterday
7:12am ET
Avadel Pharmaceuticals Shifts to Nasdaq, Ends ADR Program
Mar 22
2:46pm ET
Avadel Pharmaceuticals call volume above normal and directionally bullish
Mar 08
10:15am ET
Avadel Pharmaceuticals put volume heavy and directionally bearish
Mar 06
11:15pm ET
Buy Rating Affirmed for Avadel Pharmaceuticals Amid Strong Q4 Performance and Promising Growth Prospects
Mar 05
8:30am ET
Avadel Pharmaceuticals price target raised to $22 from $20 at Needham
Mar 05
8:30am ET
Analysts’ Top Healthcare Picks: Avadel Pharmaceuticals (AVDL), Alcon (ALC)
Mar 05
8:28am ET
Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
Mar 05
7:41am ET
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
Mar 05
6:20am ET
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Astria Therapeutics (ATXS)
Mar 05
6:06am ET
Avadel Pharmaceuticals price target raised to $25 from $21 at H.C. Wainwright
Mar 04
3:41pm ET
Avadel Pharmaceuticals ‘pleased’ with ruling in patent litigation with Jazz Pharmaceuticals
Mar 04
3:12pm ET
Avadel volatility attributed to ruling in patent fight with Jazz Pharmaceuticals
Mar 04
7:30am ET
Merus added to Conviction List at Needham
Mar 04
6:36am ET
Avadel Pharmaceuticals reports Q4 EPS (32c), consensus (29c)
Mar 01
9:01am ET
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
Feb 29
9:40am ET
Unusually active option classes on open February 29th
Feb 26
9:10am ET
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Natera (NTRA) and Agiliti (AGTI)
Feb 06
4:59am ET
Avadel Pharmaceuticals initiated with a Buy at UBS
No recent news articles are available for AVDL
No recent press releases are available for AVDL
AVDL Financials
Key terms
Ad Feedback
AVDL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AVDL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
